Loading organizations...
Point-of-care testing for precise and high-quality diagnostic results.
ProciseDx has raised $23.5M across 2 funding rounds.
ProciseDx has raised $23.5M in total across 2 funding rounds.
ProciseDx has raised $23.5M in total across 2 funding rounds.
ProciseDx's investors include Biosynex, Nestl Health Science, Larry Abensur.
ProciseDx has raised $23.5M across 2 funding rounds. Most recently, it raised $13.0M Other Equity in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 19, 2021 | $13.0M Other Equity | Biosynex, Nestl Health Science | |
| Jul 21, 2020 | $10.5M Debt / Series A | Larry Abensur |